Neyssa Marina
Publications
- A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893. Pediatr Blood Cancer. 2013; (3): 409-14
- Changes in Health Status Among Aging Survivors of Pediatric Upper and Lower Extremity Sarcoma: A Report From the Childhood Cancer Survivor Study. Arch Phys Med Rehabil. 2013
- Children's Oncology Group's 2013 blueprint for research: Bone tumors. Pediatr Blood Cancer. 2013; (6): 1009-15
- Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: A report from the Children's Oncology Group. Eur J Cancer. 2013
- Symptom cluster analyses based on symptom occurrence and severity ratings among pediatric oncology patients during myelosuppressive chemotherapy. Cancer Nurs. 2012 Jan-Feb; (1): 19-28
- Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group. Cancer. 2012; (18): 4597-605
- Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group. J Clin Oncol. 2012; (20): 2545-51
- Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma. Pediatr Blood Cancer. 2012; (4): 611-6
- An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy. Support Care Cancer. 2011; (3): 353-61
- Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2011; (6): 939-42
- High-intensity focused ultrasound (HIFU) is not indicated for treatment of primary bone sarcomas. Cancer. 2011; (12): 2822; author reply 2822-3
- Twenty years of follow-up of survivors of childhood osteosarcoma: a report from the Childhood Cancer Survivor Study. Cancer. 2011; (3): 625-34
- Changes in children's reports of symptom occurrence and severity during a course of myelosuppressive chemotherapy. J Pediatr Oncol Nurs. 2010 Nov-Dec; (6): 307-15
- Angiogenesis and vascular targeting in Ewing sarcoma: a review of preclinical and clinical data. Cancer. 2010; (3): 749-57
- Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2010; (12): 1989-94
- Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: effects on disease-free survival and immunomodulation. a report from the Children's Oncology Group. Clin Cancer Res. 2010; (15): 4024-30
- Knowledge of hepatitis C virus screening in long-term pediatric cancer survivors: a report from the Childhood Cancer Survivor Study. Cancer. 2010; (4): 974-82
- The role of interferons in the treatment of osteosarcoma. Pediatr Blood Cancer. 2010; (3): 350-4
- Multiple symptoms in pediatric oncology patients: a systematic review. J Pediatr Oncol Nurs. 2009 Nov-Dec; (6): 325-39
- Anti-insulin growth factor receptor therapy in Ewing sarcoma. F1000 Med Rep. 2009
- Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. J Clin Oncol. 2009; (15): 2536-41
- Immune approaches to treating osteosarcoma. Cancer Biol Ther. 2009; (10): 981-3
- International collaboration is feasible in trials for rare conditions: the EURAMOS experience. Cancer Treat Res. 2009: 339-53
- Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2009; (3): 324-7
- Physical performance limitations in the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009; (14): 2382-9
- Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour. Eur J Cancer. 2009; (1): 99-106
- Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2008; (4): 746-51
- Complementary and alternative therapy use in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2008; (1): 90-7
- Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee. Pediatr Blood Cancer. 2008; (2): 163-70
- Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group. Pediatrics. 2008; (2): e387-96
- Osteosarcoma: the same old drugs or more? J Clin Oncol. 2008; (18): 3102-3; author reply 3104-5
- Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2008; (3): 334-8
- Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort. Cancer. 2008; (9): 2597-604
- Challenges in the recruitment of adolescents and young adults to cancer clinical trials. Cancer. 2007; (11): 2385-93
- Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors. J Clin Oncol. 2007; (24): 3635-43
- Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006; (15): 1572-82
- Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study. J Clin Oncol. 2006; (16): 2544-8
- Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study. Cancer. 2005; (4): 841-7
- High-dose therapy and stem-cell rescue for Ewing's family of tumors in second remission. J Clin Oncol. 2005; (19): 4262-4
- Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells. Clin Cancer Res. 2005; (12): 4561-70
- Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 2004; (4): 422-41
- Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol. 2004; (24): 4979-90
- Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882. J Clin Oncol. 2004; (13): 2691-700
- Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891. J Clin Oncol. 2004; (17): 3563-9
- Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin Cancer Res. 2003; (15): 5442-53
- Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA. 2003; (12): 1583-92
- Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study. Clin Cancer Res. 2002; (2): 413-8
- Recurrent mercaptopurine-induced acute pancreatitis: a rare complication of chemotherapy for acute lymphoblastic leukemia in children. Med Pediatr Oncol. 2002; (1): 73-4
- Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial. J Clin Oncol. 2001; (1): 171-82
- New molecular targets and biological therapies in sarcomas. Cancer Treat Rev. 2001; (6): 317-26
- Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El Salvador. J Pediatr Hematol Oncol. 2000 Nov-Dec; (6): 495-501
- Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas. J Pediatr Hematol Oncol. 2000 Mar-Apr; (2): 112-8
- Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors. J Pediatr Hematol Oncol. 2000 Jul-Aug; (4): 321-9
- Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2000; (9): 3227-32
- Late effects of treatment for germ cell tumors during childhood and adolescence. J Pediatr Hematol Oncol. 1999 Mar-Apr; (2): 115-22
- Biology and therapy of pediatric malignant solid tumors. Cancer Chemother Biol Response Modif. 1999: 550-89
- Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital. J Clin Oncol. 1999; (1): 180-90
- Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study. J Clin Oncol. 1999; (7): 2137-43
- Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group. Am J Obstet Gynecol. 1999; (2): 353-8
- Nongestational choriocarcinoma in the postpartum period: a case report. J Pediatr Hematol Oncol. 1998 Mar-Apr; (2): 169-73
- Comparison of cytokines in children with recurrent solid tumors treated with intensive chemotherapy. J Pediatr Hematol Oncol. 1998 Jan-Feb; (1): 62-8
- Treatment of children with peripheral primitive neuroectodermal tumor or extraosseous Ewing's tumor with Ewing's-directed therapy. J Pediatr Hematol Oncol. 1998 Jan-Feb; (1): 55-61
- Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapy. Cancer Chemother Pharmacol. 1998; (3): 229-36
- Peritoneal metastases in children with cancer. Cancer. 1998; (2): 385-90
- Wilms' tumour. Optimal treatment strategies. Drugs. 1998; (4): 598-605
- Biology and treatment of pediatric malignant solid tumors. Cancer Chemother Biol Response Modif. 1997: 642-71
- Is primitive neuroectodermal tumor of the kidney a distinct entity? Cancer. 1997; (11): 2243-50
- Long-term survivors of childhood cancer. The medical consequences of cure. Pediatr Clin North Am. 1997; (4): 1021-42
- Phase I trial of subcutaneous interleukin-1 alpha in children with malignant solid tumors. Med Pediatr Oncol. 1997; (6): 444-50
- Cytomegalovirus causing pericarditis with tamponade in an adolescent with cancer. Med Pediatr Oncol. 1996; (1): 70
- Local control in synchronous bilateral Wilms tumor. Int J Radiat Oncol Biol Phys. 1996; (3): 541-8
- Response of pediatric malignant solid tumors following ifosfamide or ifosfamide/carboplatin/etoposide: a single hospital experience. Med Pediatr Oncol. 1996; (3): 145-8
- Sacrococcygeal yolk sac carcinoma: imaging findings during treatment. Pediatr Radiol. 1996; (3): 212-9
- St Jude Children's Research Hospital's International Outreach Program. Leukemia. 1996; (3): 570-4
- A phase I study of sulofenur in refractory pediatric malignant solid tumors. Invest New Drugs. 1995; (1): 63-6
- Serial pulmonary function studies in children treated for newly diagnosed Hodgkin's disease with mantle radiotherapy plus cycles of cyclophosphamide, vincristine, and procarbazine alternating with cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine. Cancer. 1995; (7): 1706-11
- Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapy. Med Pediatr Oncol. 1994; (4): 328-34
- Lack of heritability in ovarian germ cell malignancies. Am J Obstet Gynecol. 1994; (6): 1803-5; discussion 1805-8
- Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumors. J Natl Cancer Inst. 1994; (7): 544-8
- Phase I study of topotecan for pediatric patients with malignant solid tumors. J Clin Oncol. 1994; (3): 539-43
- Primary malignancy of the salivary gland in children. J Pediatr Surg. 1994; (1): 44-7
- Refining therapeutic strategies for patients with resistant Wilm's tumor. Am J Pediatr Hematol Oncol. 1994; (4): 296-300
- Response of immunocompromised children with solid tumors to a conjugate vaccine for Haemophilus influenzae type b. J Pediatr. 1994; (4): 581-4
- Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosis. Med Pediatr Oncol. 1994; (6): 414-6
- A phase I study of ifosfamide with Mesna given daily for 3 consecutive days to children with malignant solid tumors. Cancer. 1993; (11): 3661-5
- Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease. J Clin Oncol. 1993; (6): 1080-4
- Brain metastases in osteosarcoma. Report of a long-term survivor and review of the St. Jude Children's Research Hospital experience. Cancer. 1993; (11): 3656-60
- Candida tropicalis infections in children with leukemia. Leuk Lymphoma. 1993; (4-5): 369-76
- Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol. 1993; (1): 100-8
- Nucleoside transport in normal and neoplastic cells. Adv Enzyme Regul. 1993: 235-52
- Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors. J Clin Oncol. 1993; (3): 554-60
- Progress in the treatment of adolescents with acute lymphoblastic leukemia. Cancer. 1993; (10 Suppl): 3400-5
- Use of HBA 71 and anti-beta 2-microglobulin to distinguish peripheral neuroepithelioma from neuroblastoma. Hum Pathol. 1993; (8): 880-5
- Diagnosis and treatment of the most common solid tumors in childhood. Prim Care. 1992; (4): 871-89
- Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone. J Clin Oncol. 1992; (11): 1737-42
- Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis. Cancer. 1992; (11): 2722-7
- Leukemias and lymphomas in children. Prim Care. 1992; (4): 853-69
- Treatment of childhood germ cell tumors. Review of the St. Jude experience from 1979 to 1988. Cancer. 1992; (10): 2568-75
- Candida tropicalis and Candida albicans fungemia in children with leukemia. Cancer. 1991; (3): 594-9
- Effect of nucleoside transport inhibitors on thymidine salvage and the toxicity of nucleoside analogs in mouse bone marrow granulocyte-macrophage progenitor cells. Cancer Commun. 1991; (12): 367-72
- Infrared, thermistor, and glass-mercury thermometry for measurement of body temperature in children with cancer. Clin Pediatr (Phila). 1991; (4 Suppl): 36-41; discussion 49
- The role of second-look surgery in the management of advanced germ cell malignancies. Cancer. 1991; (2): 309-15
- Use of MR imaging to assess results of chemotherapy for Ewing sarcoma. AJR Am J Roentgenol. 1990; (2): 343-6
- Peripheral primitive neuroectodermal tumor (peripheral neuroepithelioma) in children. A review of the St. Jude experience and controversies in diagnosis and management. Cancer. 1989; (9): 1952-60
Help
Trial Administration